iRadimed
IRMD
64 hedge funds and large institutions have $86.3M invested in iRadimed in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
47% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 19
35% more capital invested
Capital invested by funds: $63.7M → $86.3M (+$22.6M)
8% more funds holding
Funds holding: 59 → 64 (+5)
5.47% more ownership
Funds ownership: 26.65% → 32.12% (+5.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
+$4.74M |
| 2 |
Renaissance Technologies
New York
|
+$2.74M |
| 3 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
+$2.5M |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$1.33M |
| 5 |
WG
Winton Group
London,
United Kingdom
|
+$638K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RC
Roubaix Capital
Denver,
Colorado
|
-$1.38M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$926K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$849K |
| 4 |
BlackRock
New York
|
-$652K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$436K |
IRMD Hedge Fund Activity: Q4 2019 in Review
64 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q4 2019, worth a combined $86.3M — up 35% from $63.7M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new IRMD positions and 2 closed out — a net gain of 5 holders — while 28 added to existing stakes and 19 trimmed.
The largest buyer was Russell Investments Group, adding an estimated $4.74M. The largest seller was Roubaix Capital, exiting entirely with an estimated $1.38M sold.
- 64 institutional investors held iRadimed (IRMD) as of Q4 2019, up from 59 in Q3 2019.
- Funds reported $86.3M of iRadimed stock for Q4 2019, up 35% quarter-over-quarter.
- 7 funds opened new iRadimed positions in Q4 2019 and 2 closed out, a net change of +5 holders.
- The largest iRadimed buyer in Q4 2019 was Russell Investments Group, an estimated $4.74M added.
- The largest iRadimed seller in Q4 2019 was Roubaix Capital, an estimated $1.38M sold.
Based on aggregated 13F filings for Q4 2019.